Clinical trial
Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia…
NCT00266357 · H. Lundbeck A/S, Industry · Terminated
Key facts
| NCT number | NCT00266357 |
|---|---|
| Title | Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED) |
| Official title | MK0928 Phase II Sleep Laboratory Study - Primary Insomnia |
| Lead sponsor | H. Lundbeck A/S, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Primary Insomnia |
| Intervention type | Drug |
| Interventions | MK0928, gaboxadol / Duration of Treatment: 6 days for treatment periods (2 days/dose), Placebo / Duration of Treatment: 2 days for screening period |
| Enrollment | 50 |
| Start date | Nov 1, 2005 |
| Primary completion | Mar 1, 2007 |
| First posted | Dec 16, 2005 |
| Last update posted | Jan 14, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: